Strong job data and a coronavirus drug have fueled US exchanges

Strong job data and encouraging test results for a Pfizer coronavirus drug have fueled US exchanges. All three selection indices left the market with fresh records. The Dow Jones index closed 0.6 percent higher to 36,327 points. The technology-heavy Nasdaq advanced 0.2 percent to 15,971 points. The broad S&P 500 gained 0.4 percent to 4697 points. In October, 531,000 new jobs outside of agriculture were created in the USA, analysts had only expected 450,000. This provided further evidence, according to traders, that the US economy is picking up momentum early in the fourth quarter. "It confirms that the economy is on the right footing, and there is a chance that the Christmas rally could be one of the strongest in recent history," said Peter Essele, director of portfolio management at wealth manager Commonwealth Financial Network. Investors were in the mood to buy, according to which a Pfizer drug reduced the likelihood of severe corona courses by 89 percent. The pharmaceutical giant's stocks jumped nearly eleven percent, while vaccine makers Moderna and Biontech fell 16.5 and 20.9 percent, respectively. "This is seen as a game changer," said a stockbroker. This applies above all to the industries particularly affected by the pandemic restrictions. "It's a quick and effective solution ... when you get a diagnosis, just take the pill and you're back on the road. The market loves it, the travel and leisure sectors love it, and we love it," said investment expert Thomas Hayes from asset manager Great Hill Capital. The shares of American Airlines, United Airlines, Delta and the cruise companies Carnival and Norwegian Cruise rose between 5.7 and 8.3 percent. Also titles from other industries that would benefit from a normalization of public life were among the winners, including cinema operators such as AMC Entertainment and the theme park operators Disney and Six Flags Entertainment. An optimistic outlook for the Christmas season helped Canada Goose to make strong gains. The shares of the supplier of high-priced down jackets rose 19.3 percent. Unlike other providers, the company does not expect any significant sales losses due to delivery bottlenecks or shipping restrictions this winter.